Crossmark

Potential therapeutic and ameliorative effects of ramipril alone and in combination with methylprednisolone for the cytokine releasing syndrome in mice: An in vivo study

Crossref DOI link: https://doi.org/10.1007/s00210-024-03659-7

Published Online: 2024-11-30

Published Print: 2025-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Al-Naimi, Marwa Salih

Abu-Raghif, Ahmed R.
License Information

Text and Data Mining valid from 2024-11-30

Version of Record valid from 2024-11-30
More Information

Article History

Received: 18 August 2024

Accepted: 19 November 2024

First Online: 30 November 2024

Declarations

:

: The study was approved by the Research Ethical Committee of the College of Medicine, Al-Nahrain University, approval number (UNCOMIRB34902024), data (4 December 2022), following the American Veterinary Association Guidelines (AVMA) (Underwood and Anthony ).

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below